PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
Fierce Biotech

Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario

A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...
Fierce Biotech

Nektar eczema candidate 'checked all of the boxes' in long-term phase 2 data

Nektar Therapeutics is basking in the honeyed glow of long-term phase 2 data for its immune asset rezpegaldesleukin in atopic ...
BioSpace

Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study

Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
EurekAlert!

Landmark Phase II study in platinum-resistant ovarian cancer to be presented at ESGO 2026

Study to be presented at this year's ESGO 2026 , demonstrates significant overall survival benefit with Elenagen plus ...
ascopubs.org

A phase II (Alliance/A091802) randomized trial of avelumab plus cetuximab vs. avelumab alone in advanced cutaneous squamous cell carcinoma (cSCC).

Phase 3 trial of adjuvant cemiplimab (cemi) versus placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...